APA (7th ed.) Citation

Bhushan B L, S., Wanve, S., Koradia, P., Bhomia, V., Soni, P., Chakraborty, S., . . . Patel, J. (2021). Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: A phase 3, randomized, comparator-controlled, open-label study. International journal of infectious diseases, 111, 281-287. https://doi.org/10.1016/j.ijid.2021.08.044

Chicago Style (17th ed.) Citation

Bhushan B L, Shashi, et al. "Efficacy and Safety of Pegylated Interferon-α2b in Moderate COVID-19: A Phase 3, Randomized, Comparator-controlled, Open-label Study." International Journal of Infectious Diseases 111 (2021): 281-287. https://doi.org/10.1016/j.ijid.2021.08.044.

MLA (9th ed.) Citation

Bhushan B L, Shashi, et al. "Efficacy and Safety of Pegylated Interferon-α2b in Moderate COVID-19: A Phase 3, Randomized, Comparator-controlled, Open-label Study." International Journal of Infectious Diseases, vol. 111, 2021, pp. 281-287, https://doi.org/10.1016/j.ijid.2021.08.044.